Beetens JR - Search Results

1

Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.

Nijkamp FP, Folkerts G, Beetens JR, De Clerck F. Nijkamp FP, et al. Among authors: beetens jr. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):111-8. doi: 10.1007/BF00169216. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2571942

2

Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.

Weber C, Beetens JR, Tegtmeier F, Van Rooy P, Vercammen E, Wouters L, De Clerck F. Weber C, et al. Among authors: beetens jr. Thromb Haemost. 1992 Aug 3;68(2):214-20. Thromb Haemost. 1992. PMID: 1412169

3

Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo.

Beetens JR, Loots W, Somers Y, Coene MC, De Clerck F. Beetens JR, et al. Biochem Pharmacol. 1986 Mar 15;35(6):883-91. doi: 10.1016/0006-2952(86)90072-9. Biochem Pharmacol. 1986. PMID: 3006695

4

5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

De Clerck F, Loots W, Somers Y, Beetens J, Wouters L, Wynants J, Janssen PA. De Clerck F, et al. Br J Pharmacol. 1990 Apr;99(4):631-6. doi: 10.1111/j.1476-5381.1990.tb12982.x. Br J Pharmacol. 1990. PMID: 2113823 Free PMC article.

5

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA. De Clerck F, et al. Thromb Haemost. 1989 Feb 28;61(1):35-42. Thromb Haemost. 1989. PMID: 2546278

6

Platelet-mediated vascular permeability in the rat: a predominant role for 5-hydroxytryptamine.

De Clerck F, Van Gorp L, Beetens J, Reneman RS. De Clerck F, et al. Thromb Res. 1985 May 15;38(4):321-39. doi: 10.1016/0049-3848(85)90132-x. Thromb Res. 1985. PMID: 3160131

7

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Vercammen E, Freyne E, Janssen PA. De Clerck F, et al. Prog Clin Biol Res. 1989;301:567-72. Prog Clin Biol Res. 1989. PMID: 2529556 No abstract available.

8

Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the rat.

De Clerck F, Van Gorp L, Beetens J, Verheyen A, Janssen PA. De Clerck F, et al. Blood Coagul Fibrinolysis. 1990 Aug;1(3):247-58. doi: 10.1097/00001721-199008000-00001. Blood Coagul Fibrinolysis. 1990. PMID: 2151728

9

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.

De Clerck F, Beetens J, Van de Water A, Vercammen E, Janssen PA. De Clerck F, et al. Thromb Haemost. 1989 Feb 28;61(1):43-9. Thromb Haemost. 1989. PMID: 2526385

10

Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations.

Weber C, Beetens JR, Van de Wiele R, Höller M, De Clerck F. Weber C, et al. Among authors: beetens jr. Blood Coagul Fibrinolysis. 1991 Feb;2(1):7-15. doi: 10.1097/00001721-199102000-00002. Blood Coagul Fibrinolysis. 1991. PMID: 1773000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters